Clazakizumab Completed Phase 2 Trials for Antibody Mediated Rejection Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03444103 | A Pilot Trial of Clazakizumab in Late ABMR |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03444103 | A Pilot Trial of Clazakizumab in Late ABMR |